Mass Spec Meets Oncology

Premium

By William Langbein

 

Since the 1990s, monitoring biomarkers in the blood has been one of few noninvasive tools that an oncologist can use to diagnose cancer. Reliance on single biomarkers has been driven by a chemistry approach to research and wet lab technologies such as 2D gel electrophoresis — one antigen or protein can be isolated, characterized, and clinically linked to the presence of an invading tumor or cancer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.